Malaga Cove Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Sell
2,160
-190
-8% -$23.3K 0.09% 162
2026
Q1
$277K Buy
2,350
+384
+20% +$53.6K 0.1% 172
2025
Q4
$322K Sell
1,966
-16
-0.8% -$2.51K 0.11% 171
2025
Q3
$265K Buy
+1,982
New +$241K 0.1% 164
2024
Q3
Sell
-5,906
Closed -$745K 191
2024
Q2
$745K Buy
5,906
+1,448
+32% +$227K 0.3% 86
2024
Q1
$820K Hold
4,458
0.33% 83
2023
Q4
$802K Buy
4,458
+1,961
+79% +$305K 0.34% 83
2023
Q3
$397K Hold
2,497
0.18% 126
2023
Q2
$353K Buy
+2,497
New +$400K 0.16% 127

Other funds holding RGEN

Malaga Cove Capital's RGEN Position: Q2 2026 in Review

Malaga Cove Capital reduced its Repligen (RGEN) stake by 8.1% in Q2 2026, selling an estimated $23.3K and leaving 2,160 shares worth $295K. The position accounts for 0.09% of the portfolio, ranked #162.

Malaga Cove Capital first reported a position in RGEN in Q2 2023 and has held it in 9 quarters since. The position peaked at $820K in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Malaga Cove Capital held 2,160 shares of Repligen worth $295K as of Q2 2026.
  • Malaga Cove Capital sold 190 Repligen shares in Q2 2026, an estimated $23.3K.
  • Repligen made up 0.09% of Malaga Cove Capital's portfolio in Q2 2026, its #162 holding.
  • Malaga Cove Capital first reported a position in Repligen in Q2 2023 and has held it in 9 quarters since.
  • Malaga Cove Capital's Repligen position peaked at $820K in Q1 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Malaga Cove Capital's 13F filing for Q2 2026, filed 24 Jul 2026.